Johansson L, Lefèvre J P, Schröder R. "Method for the Synthesis of 2-Hydrazinyl-3-(3-propyl-1,2,4-oxadiazol-5-yl)pyridine" [P]. European Patent, EP 3570997 A1, 2018-03-18.
发明人罗永刚,何建平,林芳. "A Process for Preparing High-Purity 2-Hydrazinyl-3-(3-propyl-1,2,4-oxadiazol-5-yl)pyridine" [P]. 中国发明专利, 专利号 CN 116952354 A, 授权公告日 2018-12-04.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2010, 2253, 1113-1135.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2018, 1359, (11), 3917-3926.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 2-Hydrazinyl-3-(3-propyl-1,2,4-oxadiazol-5-yl)pyridine Using HRMS and NMR". Talanta, 2024, 510, (11), 7978-8005.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 2099, 1216-1228.